Your institution is subscribed to Read Institutional Edition. Log in or Sign Up to read full text articles.


[Revascularization for the aortoiliac regions of peripheral arterial disease]

Yukio Obitsu, Hiroshi Shigematsu
Nihon Geka Gakkai Zasshi 2010, 111 (2): 79-83
As far as the indications for revascularization in the abdominal aortoiliac region are concerned, endovascular therapy is recommended for TASC II type A and type B lesions, and surgical bypass is recommended for TASC II type C and type D lesions. As stents have been developed and used more frequently in recent years, the results for endovascular therapy have dramatically improved, and its indications are beginning to be expanded. Endovascular therapy is the first-live therapy for stenotic lesions smaller than 10 cm in length or bilateral common or external iliac artery occulusion (type A and type B lesions). For highly skilled surgeons, endovascular therapy is the first-line therapy for type C and type D lesions exclude aorta and common femoral artery lesions. Therefore, when performing endovascular therapy for type C and type D lesions, it is necessary to sufficiently evaluate not only the skill of the surgeon, patient risk and QOL, but also revascularization. Furthermore, it is imperative to consider therapeutic options when endovascular therapy ends in failure.

Full Text Links

Find Full Text Links for this Article


You are not logged in. Sign Up or Log In to join the discussion.

Trending Papers

Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.